Enhanced expression of salusin-β contributes to progression of atherosclerosis in LDL receptor deficient mice
Authors:
- 1 April 2012
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 90 (4) , 463-471
Abstract
Atherosclerosis is an important underlying pathology of cardiovascular diseases. The aim of this study was to observe the expression of salusin-β, a new vasoactive peptide, in vascular tissues of low-density lipoprotein receptor deficient (LDLR–/–) mice, and to evaluate the effect of salusin-β on the development of atherosclerosis in LDLR–/– mice. Six-week-old, male LDLR–/– mice were subcutaneously injected with salusin-β or the vehicle, once a day for 12 weeks. The expressions of salusin-β in both mRNA and peptide levels were determined by reverse transcription – polymerase chain reaction, Western blot, and immunohistochemistry. Atherosclerotic lesions were analyzed by staining with hematoxylin and eosin or oil red O. Our results showed that expression of salusin-β in mRNA and salusin-β peptide levels were enhanced in LDLR–/– mice. Subcutaneous injection of salusin-β significantly aggravated the atherosclerotic lesions, and increased lipid deposits in the arteries of LDLR–/– mice. Moreover, salusin-β significantly increased the serum level of low-density lipoprotein cholesterol, but not total cholesterol, triglycerides, or high-density lipoprotein cholesterol. These results suggest that the enhanced expression of salusin-β contributes to progression of atherosclerosis in LDLR–/– mice by up-regulating the serum low-density lipoprotein cholesterol level. This study provides a potential therapeutic target for the prevention and treatment of atherosclerosis.Keywords
This publication has 17 references indexed in Scilit:
- Chronic infusion of salusin-α and -β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient miceAtherosclerosis, 2010
- Presence of immunoreactive salusin-β in human plasma and urineRegulatory Peptides, 2009
- Impact of Plasma Oxidized Low-Density Lipoprotein Removal on AtherosclerosisCirculation, 2008
- Fatores de risco no desenvolvimento da aterosclerose na infância e adolescênciaArquivos Brasileiros de Cardiologia, 2008
- Chronic Osmotic Stimuli Increase Salusin‐β‐Like Immunoreactivity in the Rat Hypothalamo‐Neurohypophyseal System: Possible Involvement of Salusin‐β on [Ca2+]i Increase and Neurohypophyseal Hormone Release from the Axon TerminalsJournal of Neuroendocrinology, 2007
- Systemic Distribution of Salusin Expression in the RatHypertension Research, 2007
- Presence of immunoreactive salusin-α in human serum and urinePeptides, 2006
- Coexistence of salusin and vasopressin in the rat hypothalamo-hypophyseal systemNeuroscience Letters, 2005
- Synthetic Salusins as Cardiac Depressors in RatHypertension, 2005
- Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activitiesNature Medicine, 2003